Octreotide in insulinoma patients: efficacy on hypoglycemia, relationships with Octreoscan scintigraphy and immunostaining with anti-sst2A and anti-sst5 antibodiesDelphine Vezzosi, Philippe Caron, Antoine Bennet et al.|European Journal of Endocrinology|2005Cited by 183
Long‐term (up to 18 years) effects on GH/IGF‐1 hypersecretion and tumour size of primary somatostatin analogue (SSTa) therapy in patients with GH‐secreting pituitary adenoma responsive to SSTaJean Christophe Maiza, Philippe Caron, Delphine Vezzosi et al.|Clinical Endocrinology|2007Cited by 121
Impaired quality of life of patients with acromegaly: control of GH/IGF-I excess improves psychological subscale appearanceMaria Matta, Philippe Caron, Elisabeth Couture et al.|European Journal of Endocrinology|2008Cited by 105
Primary Medical Treatment of Thyrotropin–Secreting Pituitary Adenomas by First-Generation Somatostatin Analogs: A Case Study of Seven PatientsFrédérique Rimareix, Philippe Caron, Solange Grunenwald et al.|Thyroid|2015Cited by 31
Decreased IGF-1 concentration during the first trimester of pregnancy in women with normal somatotroph functionMarie-Laure Persechini, Philippe Caron, Isabelle Gennero et al.|Pituitary|2014Cited by 30